A patient suffering from both ALS and myasthenia gravis (MG) showed significant improvement in cognitive and motor function following treatment with BrainStorm Cell Therapeutics adult stem cells, according to a published case report.

A 75 year-old-man diagnosed with both MG and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, was treated with BrainStorm's NurOwn cells. Both are neurodegenerative diseases, Newsmax Health reports.

One month after receiving injections of the cells, the patient and his family reported significant improvement in cognition, speech, and muscle power.

After six months, due to progression of weakness and deterioration in cognition, a repeat injection of NurOwn was performed. Again, improvements in the ALS functional rating scale were observed, the report said, adding that treatment with NurOwn appeared safe and well tolerated.